Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis

Carpenter, EL; Van Decar, S; Adams, AM; O'Shea, AE; McCarthy, P; Chick, RC; Clifton, GT; Vreeland, T; Valdera, FA; Tiwari, A; Hale, D; Bohan, PK; Hickerson, A; Smolinsky, T; Thomas, K; Cindass, J; Hyngstrom, J; Berger, AC; Jakub, J; Sussman, JJ; Shaheen, MF; Yu, XZ; Wagner, TE; Faries, M; Peoples, GE

Van Decar, S (通讯作者)，Brooke Army Med Ctr, Dept Surg, Ft Sam Houston, TX 78234 USA.

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023; 11 (8):

Abstract

Background The tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine is made by ex vivo priming matured autologous dendritic cells (DCs) with......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索